ATE156136T1 - Peptidfragment des menschlichen villins und antikörper dagegen - Google Patents

Peptidfragment des menschlichen villins und antikörper dagegen

Info

Publication number
ATE156136T1
ATE156136T1 AT92105747T AT92105747T ATE156136T1 AT E156136 T1 ATE156136 T1 AT E156136T1 AT 92105747 T AT92105747 T AT 92105747T AT 92105747 T AT92105747 T AT 92105747T AT E156136 T1 ATE156136 T1 AT E156136T1
Authority
AT
Austria
Prior art keywords
villin
peptide fragment
human villin
antibodies against
antibodies
Prior art date
Application number
AT92105747T
Other languages
English (en)
Inventor
Daniel Louvard
Brigitte Dudouet
Sylvie Robine
Monique Arpin
Eric Pringault
Alphonse Garcia
Original Assignee
Pasteur Institut
Centre Nat Rech Scient
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8506707A external-priority patent/FR2581456B1/fr
Priority claimed from FR8516820A external-priority patent/FR2589882B2/fr
Application filed by Pasteur Institut, Centre Nat Rech Scient, Inst Nat Sante Rech Med filed Critical Pasteur Institut
Application granted granted Critical
Publication of ATE156136T1 publication Critical patent/ATE156136T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4735—Villin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3046—Stomach, Intestines
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT92105747T 1985-05-02 1986-04-30 Peptidfragment des menschlichen villins und antikörper dagegen ATE156136T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8506707A FR2581456B1 (fr) 1985-05-02 1985-05-02 Villine humaine, en tant que marqueur de cellules malignes primaires originaires du tube digestif, et moyens, en particulier anticorps diriges contre la villine humaine, pour la detection desdites cellules malignes
FR8516820A FR2589882B2 (fr) 1985-11-13 1985-11-13 Moyens pour le diagnostic in vitro de cellules malignes originaires du tube digestif

Publications (1)

Publication Number Publication Date
ATE156136T1 true ATE156136T1 (de) 1997-08-15

Family

ID=26224488

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92105747T ATE156136T1 (de) 1985-05-02 1986-04-30 Peptidfragment des menschlichen villins und antikörper dagegen

Country Status (4)

Country Link
EP (2) EP0206849B1 (de)
JP (4) JP2698326B2 (de)
AT (1) ATE156136T1 (de)
DE (2) DE3650641T2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5635389A (en) * 1985-05-02 1997-06-03 Institut Pasteur Antibodies which recognize and bind human villin
FR2638464B1 (fr) * 1988-10-28 1992-01-03 Pasteur Institut Fragments d'acide nucleique specifiques du gene de la villine humaine, leur utilisation aux fins de diagnostic
FR2645877B1 (fr) * 1989-04-12 1991-07-05 Pasteur Institut Molecules comportant au moins une sequence peptidique porteuse d'un, ou plusieurs, epitope caracteristique d'une proteine produite par p. falciparum au niveau du stade sporozoite et dans les hepatocytes
US5830729A (en) 1996-04-18 1998-11-03 Institut Pasteur I Sce I-induced gene replacement and gene conversion in embryonic stem cells
JP7158642B2 (ja) * 2018-01-16 2022-10-24 国立大学法人山梨大学 質量分析装置及び質量分析システム

Also Published As

Publication number Publication date
EP0502553A3 (en) 1994-05-25
JP2698326B2 (ja) 1998-01-19
JPH11123091A (ja) 1999-05-11
EP0206849B1 (de) 1993-09-29
WO1986006494A3 (fr) 1987-03-26
WO1986006494A2 (fr) 1986-11-06
DE3650641D1 (de) 1997-09-04
EP0502553A2 (de) 1992-09-09
DE3689084T2 (de) 1994-04-28
EP0206849A3 (en) 1987-08-05
DE3689084D1 (de) 1993-11-04
DE3650641T2 (de) 1998-03-05
JPH07188300A (ja) 1995-07-25
EP0502553B1 (de) 1997-07-30
JP2698337B2 (ja) 1998-01-19
EP0206849A2 (de) 1986-12-30
JPH08208699A (ja) 1996-08-13
JPH1066574A (ja) 1998-03-10

Similar Documents

Publication Publication Date Title
ATE294864T1 (de) Äusseres membranprotein von haemophilus
DE69634726D1 (de) Menschliche ctla-8 und verwendung von ctla-8 ähnlichen proteinen
DE3650751D1 (de) Antikörper gegen Saugetier-Interleukin-4 und Peptide verwendbar als Antigenen für deren Herstellung
BG60256B1 (bg) Рекомбинантен метод за получаване на лимфотоксин
BR9500732A (pt) Peptídio imunologicamente ativo,fragmento de DNA isolado,kit de teste e aplicação
ATE105869T1 (de) Formen des koloniestimulierungsfaktors 1.
ATE63138T1 (de) Komplementaere polypeptide gegen peptide oder proteine mit mindestens teilweise bekannter aminosaeure- oder nukleotidkodierender sequenz und diesbezuegliches aufbauverfahren.
ATE123291T1 (de) Biologisch aktive bakterientötende/durchlässigkeitserhöhende proteinfragmente.
IT8119760A0 (it) Polipeptide prodotto microbiologicamente con la sequenza di aminoacidi dell'interferone umano, dna e plasmidi che codificano per questa sequenza, microorganismi che contengono queste informazioni genetiche e processo per la loro preparazione.
DE69334350D1 (de) P- Selectin Ligandenprotein
ES548617A0 (es) Procedimiento para disociar peptidos y proteinas en el enla-ce metionilo
NO940299L (no) Peptid med organbeskyttende aktivitet
SE8505920D0 (sv) New protein and its use
ATE156136T1 (de) Peptidfragment des menschlichen villins und antikörper dagegen
ATE112289T1 (de) Hämoregulierende peptide.
ES8700272A1 (es) Procedimiento para la preparacion y purificacion de peptidos
DK1431391T3 (da) RANTES-mutanter og terapeutiske anvendelser heraf
DK38889D0 (da) Onkogen-indkodet polypeptid med vaekstfaktoraktivitet
SE8801723D0 (sv) Fibronectin binding protein as well as its preparation
FI943218L (fi) Kaseinomakropeptidin peptidit, mainittujen peptidien vasta-aineet ja käytöt
EP0723016A3 (de) Leukocyten-aktivierender Faktor
NO921219D0 (no) Somatostatin reseptor
EP0272894A3 (de) Rekombinantes menschliches Lymphotoxin
FR2744122B1 (fr) Nouveaux agents edulcorants derivant de l'acide n-(4-cyanophenylcarbamoyl ou 2-cyanopyrid-5-ylcarbamoyl)-l- aspartique alpha-benzenamide 3-monosubstitue
KR880006359A (ko) 사람의 tiits를 제조하기 위한 중간물질로서의 균일한 양 tiits 및 이의 용도

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee